Pharmaceutical co-crystals are novel class of pharmaceutical substances, which possess an
apparent probability of advancement of polished physical properties offering stable and …

Pharmaceutical co-crystals have been explored by many researchers as a strategy to
optimize physicochemical properties of solid-state drugs. Their improvements of solubility …

The non-steroidal anti-inflammatory drugs mefenamic acid (MFA) and tolfenamic acid (TFA)
have a close resemblance in their molecular scaffold, whereby a methyl group in MFA is …

The present work deals with the preparation of drug–drug cocrystals of mefenamic acid
(MEF) with paracetamol (PAR) using gas antisolvent (GAS) process with an aim to improve …

New ternary lanthanide complexes with mefenamic acid (Hmef) and phenanthroline with the
stoichiometry Ln 2 (mef) 5 (phen)(OH)· nH 2 O (Ln= La and Ce) and Ln 2 (mef) 4 (phen)(OH) …

A new system drugs derivative was designed from Mefenamic Acid. These derivatives have
been synthesized by reaction between mefenamic acid and different amino drugs via amide …

The present study explores the possibility to synthetize, using supercritical fluid, single
crystal of co-crystal formed by mefenamic acid as active pharmaceutical ingredient and …

A cocrystal of mefenamic acid (MA)-nicotinamide (NA) has been reported to increase the
solubility of MA, but it still does not exceed the solubility of sodium mefenamate (SM) …

Mixed-ligand metal complexes are being prepared under solvent-free conditions and this
has formed a vital ongoing research focus. One of the purposes is to overcome antimicrobial …

Every" entity" or compound has physical and chemical properties as references for the
synthesis and determination of the entity's structure. Thermodynamically, solid-state is the …